REPLAGAL
REPLAGAL
Approved
DIN Number
02249057
Drug Class
Human
Market Date
Mar 18, 2004
Company
HC
takeda canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02249057
AIG Number0149941001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
A16AB03 AGALSIDASE ALFA
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
AGALSIDASE ALFAActive
Strength: 1 MG / ML
Monograph: AGALSIDASE ALFA